Formulación y biodisponibilidad de nuevos medicamentos
University of California, Davis
Davis, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California, Davis (2)
2023
-
Biological evaluation of integrin α3β1-targeted 68Ga-labeled HEVNPs in HCT 116 colorectal tumor-bearing mice
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 180, pp. 106336
2022
-
Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics
Nuclear Medicine and Biology, Vol. 114-115, pp. 151-161